Search research articles
Contact Us
Filters
Showing results (11-20 of 578) with videos related to
Page
of 58
Sort By:
Current Opinion in Oncology
|
November 19, 2003
Treatment of patients with early epithelial ovarian cancer
Ignace Vergote, Baptist J Trimbos
Therapeutic Advances in Medical Oncology
|
July 3, 2015
Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors
Ignace Vergote, Christopher P Leamon
European Journal of Cancer (Oxford, England : 1990)
|
September 29, 2023
New FIGO 2023 endometrial cancer staging validation. Welcome to the first molecular classifiers and new pathological variables!
Ignace Vergote, Xavier Matias-Guiu
Anti-Cancer Drugs
|
October 22, 2003
A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours
John Hainsworth, Ignace Vergote, Jacques Janssens
Anti-Cancer Drugs
|
October 22, 2003
ZD9331 in combination with topotecan: phase I and II experience
Al Benson, Elizabeth Poplin, Ignace Vergote
Gynecologic Oncology
|
December 14, 2011
Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges?
Ignace Vergote, Karin Leunen, Frédéric Amant
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2019
Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?
Ignace Vergote, Philipp Harter, Luis Chiva
Gynecologic Oncology
|
September 14, 2010
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
Ignace Vergote, Frederic Amant, Karin Leunen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Is it safe to treat endometrial carcinoma endoscopically?
Ignace Vergote, Frederic Amant, Patrick Neven
Lancet (London, England)
|
April 7, 2009
Lymphadenectomy in endometrial cancer
Frédéric Amant, Patrick Neven, Ignace Vergote
Page
of 58
Search research articles
Search
Showing results (11-20 of 578) with videos related to
Sort By:
Page
of 58
Current Opinion in Oncology
|
November 19, 2003
Treatment of patients with early epithelial ovarian cancer
Ignace Vergote, Baptist J Trimbos
Therapeutic Advances in Medical Oncology
|
July 3, 2015
Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors
Ignace Vergote, Christopher P Leamon
European Journal of Cancer (Oxford, England : 1990)
|
September 29, 2023
New FIGO 2023 endometrial cancer staging validation. Welcome to the first molecular classifiers and new pathological variables!
Ignace Vergote, Xavier Matias-Guiu
Anti-Cancer Drugs
|
October 22, 2003
A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours
John Hainsworth, Ignace Vergote, Jacques Janssens
Anti-Cancer Drugs
|
October 22, 2003
ZD9331 in combination with topotecan: phase I and II experience
Al Benson, Elizabeth Poplin, Ignace Vergote
Gynecologic Oncology
|
December 14, 2011
Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges?
Ignace Vergote, Karin Leunen, Frédéric Amant
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2019
Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?
Ignace Vergote, Philipp Harter, Luis Chiva
Gynecologic Oncology
|
September 14, 2010
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
Ignace Vergote, Frederic Amant, Karin Leunen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Is it safe to treat endometrial carcinoma endoscopically?
Ignace Vergote, Frederic Amant, Patrick Neven
Lancet (London, England)
|
April 7, 2009
Lymphadenectomy in endometrial cancer
Frédéric Amant, Patrick Neven, Ignace Vergote
Page
of 58